1.Pharmacokinetics of the combined preparation of lisinopril and hydrochlorothiazide on Chinese healthy volunteers.
Yang WEI ; Yingying SUN ; Keshen WANG ; Danli SUN ; Mingyou ZHENG
Acta Pharmaceutica Sinica 2011;46(8):955-61
The aim of the present study, performed on two different groups of volunteers, is to characterize the pharmacokinetics of lisinopril/hydrochlorothiazide combined tablet. After administration of high, medium and low doses of lisinopril/hydrochlorothiazide combined tablets, AUC and C(max) of two compounds both increase significantly with increase of dose. Neither normalized AUC/Dose nor C(max)/Dose has significant difference between every two tested dose groups. The similar results can be observed as for the parameters of t(max). Lisinopril and hydrochlorothiazide are both eliminated with linear characteristics. After repeated administration of lisinopril/hydrochlorothiazide combined tablets, AUC, C(max) and C(min) of lisinopril in the steady state increase. AUC and C(min) increase significantly. As for hydrochlorothiazide, AUC, C(max), C(min), and t(max) also increase in steady state. AUC and C(min) increase significantly. Administered with the test medication, lisinopril has an fluctuation index (FI) value of 2.29 and reaches a relative steady concentration. But hydrochlorothiazide has an FI value of 4.09 with relatively large fluctuating concentrations.
2.Overexpression of CLN3 gene in human ovarian carcinoma
Dongwei MAO ; Yiping ZHAO ; Keshen LI ; Xiaoming WANG
Chinese Journal of Pathophysiology 1999;0(09):-
AIM: To determine whether overexpression of CLN3 is involved in the tumorigenesis of ovarian cacinoma. METHODS: 10 specimens of ovarian carcinoma were screened for CLN3 gene expression level by semiquantitative RT-PCR and Western blotting. RESULTS: Overexpression of CLN3 mRNA and protein was found in all ovarian tumor tissues as compared with normal tissues. CONCLUSION: The overexpression of CLN3 may contribute to tumor development of ovarian cancer.
3.Electrolyzed Oxidizing Water Disinfection in Disinfection Supply Center of Peking University First Hospital:An Application Study
Hong TIAN ; Jinxia NIU ; Keshen ZHANG ; Wuai REN ; Dong YU ; Jin WANG ; Min LI
Chinese Journal of Nosocomiology 2009;0(17):-
1.0,achieved the standard request of Disinfection Technology standard.RESULTS Through EOW disinfection,the bacteria were not found on the object surfac of transports and conformed to the object surface disinfection request of Disinfection Technology Standard.CONCLUSIONS Applying EOW to disinfection of polluted instrument recycling vehicle for clinical purpose can fulfill the State standards completely;EOW has strongly germicidal activity,also with characteristics as rapidity,safety and environment security,without any irritant odor.These results indicate a widely potential use of EOW as in hospital disinfection supply center,especially,with a positive significance in health care for pediatric patients.
4.Progress in study on the treatment of gastric cancer with docetaxel
Gengyuan ZHANG ; Hengrui DU ; Zhenjiang WANG ; Yanxian REN ; Keshen WANG ; Zuoyi JIAO
Journal of Central South University(Medical Sciences) 2018;43(2):216-221
Gastric cancer is one of the most common malignant gastrointestinal tumors.Docetaxel alone or combination with other drugs can attenuate the progress of disease,prolong the overall response rate and the median overall survival rate in advanced gastric cancer.However,the incidence of toxicities is high.Moreover,there is no uniform standard for dosage and course for docetaxel treatment.Currently,its efficacy is not definite.
5.Research progress of the FLOT regimen in neoadjuvant treatment for gastric cancer
Tao WANG ; Keshen WANG ; Huinian ZHOU ; Zeyuan YU ; Zuoyi JIAO
Chinese Journal of Digestive Surgery 2022;21(6):822-826
With the deepening research of comprehensive treatment for gastric cancer, the FLOT regimen has begun to be used for the treatment of gastric cancer patients. FLOT neoadjuvant regimen can significantly improve the R 0 resection rate and prolong the overall survival time of locally advanced gastric cancer patients. FLOT regimen combined with immune-checkpoint inhibi-tors, targeted therapy and hyperthermic intraperitoneal chemotherapy have great potential in neo-adjuvant therapy for gastric cancer. The authors systematically analyse the development history and latest clinical research progress of FLOT neoadjuvant regimen for gastric cancer based on their clinical practice experience.
6.Research advance in gastric neuroendocrine tumors.
Zhenjiang WANG ; Yuxian GU ; Yanxian REN ; Keshen WANG ; Zhijian MA ; Zuoyi JIAO
Journal of Central South University(Medical Sciences) 2019;44(1):92-99
Gastric neuroendocrine tumors are rarely seen in the gastric tumors, because there are few case reports and the clinical diagnosis rate is low. There is no consensus treatment method in the world. However, with the benefit of esophagogastrodenoscopy and widespread use of proton pump inhibitors, the diagnostic rate of gastric neuroendocrine tumors is on the increase, which gives us an updated understanding for the pathogenesis and pathophysiology of the disease. By studying its pathogenesis, scholars have found that hypergastrinemia caused by various causes is closely related to its occurrence. Gastric neuroendocrine tumors are classified into different types or pathological grades depending on the state of progression of the disease and the unique clinical manifestations. Clinically used diagnostic methods include gastroscopy, medical imageology, nuclear medicine, gastrin, CgA, etc. There are also differences in treatments depending on the clinical classification. If the disease progresses rapidly and the grade is high, surgical resection of the lesion plus postoperative adjuvant chemotherapy should be actively performed. Other better treatments are still being explored.
Gastrins
;
Gastroscopy
;
Humans
;
Neuroendocrine Tumors
;
Proton Pump Inhibitors
;
Stomach Neoplasms